<SEC-DOCUMENT>0001641172-25-015686.txt : 20250620
<SEC-HEADER>0001641172-25-015686.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620061132
ACCESSION NUMBER:		0001641172-25-015686
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viewbix Inc.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288164
		FILM NUMBER:		251058975

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		3 HANEHOSHET ST, BUILDING B
		STREET 2:		7TH FLOOR
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		ZIP:			6971068
		BUSINESS PHONE:		855-879-8439

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		3 HANEHOSHET ST, BUILDING B
		STREET 2:		7TH FLOOR
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		ZIP:			6971068

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virtual Crypto Technologies, Inc.
		DATE OF NAME CHANGE:	20180312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Medical Applications Corp.
		DATE OF NAME CHANGE:	20151006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forms-1.htm
<DESCRIPTION>S-1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center"><B>As filed with the Securities and
Exchange Commission on June 20, 2025 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED STATES</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>SECURITIES AND
EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Washington, D.C.
20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FORM S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>VIEWBIX INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>6770</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>68-0080601</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of<BR>
    incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Primary Standard Industrial<BR>
    Classification Code Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer<BR>
    Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>3 Hanehoshet St, Building B, 7th floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel Aviv, Israel 6971068<BR>
+972-9774-1505<BR>
</B>(Address, including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Puglisi &amp; Associates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>850 Library Ave., Suite 204</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Newark, DE 19711</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (302) 738-6680<BR>
</B>(Name, address, including zip code, and telephone number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies of all communications, including
communications sent to agent for service, should be sent to</I>:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>David Huberman, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Michael Soumas, Esq.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Greenberg Traurig, P.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>One Azrieli Center</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Round Tower, 30th floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>132 Menachem Begin Rd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel Aviv, Israel 6701101</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone: +972 (0) 3.636.6000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Approximate date of commencement
of proposed sale to the public:</B> As soon as practicable after this registration statement is declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the securities
being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,
check the following box. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is filed to
register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See definition of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Smaller Reporting Company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Emerging Growth Company</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The registrant hereby
amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section
8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. The selling stockholder named in this prospectus may not sell these securities until
the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these
securities and the selling stockholder named in this prospectus are not soliciting an offer to buy these securities in any state where
the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase; color: Red"><B>SUBJECT
TO COMPLETION, DATED JUNE 20, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>PRELIMINARY PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,296,610 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><IMG SRC="image_001.jpg" ALT="" STYLE="width: 235px; height: 46px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Viewbix Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the resale, from time to time, by the selling stockholder identified in this prospectus, or the selling stockholder, of up to 5,296,610
shares of our common stock, par value $0.0001 per share issuable upon the exercise of warrants issued in connection a credit facility
that we entered into in June 2024, as further described below under &ldquo;Prospectus Summary &#8212; Recent Developments &#8212;June
2024 Facility Agreement&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholder is
identified in the table commencing on page 8. Other than as described above, we will not receive any proceeds from the sale of the
shares of common stock by the selling stockholder. All net proceeds from the sale of the shares of common stock covered by this prospectus
will go to the selling stockholder. However, we may receive the proceeds from any exercise of warrants if the holders do not exercise
the warrants on a cashless basis. See &ldquo;Use of Proceeds.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholder may
sell all or a portion of the shares of common stock from time to time in market transactions through any market on which our shares of
common stock are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then
prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as <FONT STYLE="font-size: 10pt">principal
or by a combination of such methods of sale. See &ldquo;Plan of Distribution&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market, or Nasdaq, under the symbol &ldquo;VBIX&rdquo;. On June 18, 2025,
the last reported sale price of our common stock on the Nasdaq was $4.04 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. These risks are discussed in this prospectus under &ldquo;Risk Factors&rdquo; beginning
on page 6 and in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are incorporated by reference
in this prospectus and in any applicable prospectus supplement.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">The date of this
prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>TABLE OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; text-align: center; width: 91%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 9%; text-align: center"><FONT STYLE="font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt">1</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt">8</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">SELLING STOCKHOLDER</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt">8</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF THE OFFERED SECURITIES</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: white">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font-size: 10pt"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">15</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC. As permitted by
the rules and regulations of the SEC, the registration statement filed by us includes additional information not contained in this prospectus.
You may read the registration statement and the other reports we file with the SEC at the SEC&rsquo;s website or its offices described
below under the heading &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">You
should rely only on the information that is contained in this prospectus. We have not authorized anyone to provide you with information
that is in addition to or different from that contained in this prospectus. If anyone provides you with different or inconsistent information,
you should not rely on it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are not offering to sell or solicit any security other than the shares of common stock offered by this prospectus. In addition, we are
not offering to sell or solicit any securities to or from any person in any jurisdiction where it is unlawful to make this offer to or
solicit an offer from a person in that jurisdiction. The information contained in this prospectus is accurate as of the date on the front
of this prospectus only, regardless of the time of delivery of this prospectus or of any sale of our shares of common stock. Our business,
financial condition, results of operations and prospects may have changed since that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">All
trademarks or trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks
and trade names in this prospectus are referred to without the <SUP>&reg;</SUP> and <SUP>&#8482;</SUP> symbols, but such references should
not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights
thereto. We do not intend the use or display of other companies&rsquo; trademarks and trade names to imply a relationship with, or endorsement
or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed as exhibits to the registration statement, and you may obtain copies of those documents
as described below under the section entitled &ldquo;Where You Can Find More Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
financial statements are prepared and presented in accordance with United States generally accepted accounting principles, or U.S. GAAP.
Our historical results do not necessarily indicate our expected results for any future periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Market
data and certain industry data and forecasts used throughout this prospectus were obtained from sources we believe to be reliable, including
market research databases, publicly available information, reports of governmental agencies and industry publications and surveys. We
have relied on certain data from third-party sources, including internal surveys, industry forecasts and market research, which we believe
to be reliable based on our management&rsquo;s knowledge of the industry. Forecasts are particularly likely to be inaccurate, especially
over long periods of time. In addition, we do not necessarily know what assumptions regarding general economic growth were used in preparing
the third-party forecasts we cite. Statements as to our market position are based on the most currently available data. While we are
not aware of any misstatements regarding the industry data presented in this prospectus, our estimates involve risks and uncertainties
and are subject to change based on various factors, including those discussed under the heading &ldquo;Risk Factors&rdquo; in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Certain
figures included in this prospectus have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables
may not be an arithmetic aggregation of the figures that precede them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Unless
the context otherwise requires, references to &ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us,&rdquo; &ldquo;Viewbix&rdquo; or the &ldquo;Company&rdquo;
in this prospectus mean Viewbix Inc. and its consolidated subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
reporting currency and functional currency is the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references
in this prospectus to &ldquo;NIS&rdquo; are to New Israeli Shekels, and references to &ldquo;dollars&rdquo; or &ldquo;$&rdquo; mean U.S.
dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
March 14, 2025, we effected a one-for-four consolidation of our share capital, or the Reverse Split, pursuant to which holders of our
shares of common stock received one share of common stock for every four shares of common stock held. Unless the context expressly indicates
otherwise, all references to share and per share amounts referred to herein reflect the amounts after giving effect to the Reverse Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="font-size: 10pt; padding: 5pt; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_002"></A>PROSPECTUS SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>The
following summary highlights certain information contained elsewhere in or incorporated by reference into this prospectus. Because this
is only a summary, however, it does not contain all the information you should consider before investing in our securities and it is
qualified in its entirety by, and should be read in conjunction with, the more detailed information included elsewhere in or incorporated
by reference into this prospectus. Before you make an investment decision, you should read this entire prospectus carefully, including
the risks of investing in our securities discussed under the section of this prospectus entitled &ldquo;Risk Factors&rdquo; and similar
headings in the other documents that are incorporated by reference into this prospectus. You should also carefully read the information
incorporated by reference into this prospectus, including our financial statements, and the exhibits to the registration statement of
which this prospectus is a part.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Viewbix
is a digital advertising platform that develops and markets a variety of technological platforms that automate, optimize and monetize
digital online campaigns. Viewbix&rsquo;s operations were previously focused on analysis of the video marketing performance of its clients
as well as the effectiveness of their messaging (&ldquo;Video Advertising Platform&rdquo;). With the Video Advertising Platform, Viewbix
allowed its clients with digital video properties the ability to use its platforms in a way that allows viewers to engage and interact
with the video. The Video Advertising Platform measures when a viewer performs a specific action while watching a video and collects
and reports the results to the client. However, due to the Company&rsquo;s failure to meet predetermined sales targets which were set
pursuant to the recapitalization transaction with Gix Internet Ltd. in January 2020, the Company determined to reduce its operations
and the size of its sales and R&amp;D team in the Digital Advertising Platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Company, through its subsidiaries, Gix Media Ltd. (&ldquo;Gix Media&rdquo;) and Cortex Media Group Ltd. (&ldquo;Cortex&rdquo;), expanded
its digital advertising operations across two main sectors: ad search and digital content (the &ldquo;Search Platform&rdquo; and the
&ldquo;Content Platform&rdquo;, respectively&rdquo;). Gix Media and Cortex develop and market a variety of technological software solutions
that automate, optimize and monetize online campaigns. Cortex also creates, edits and markets content in various languages to different
target audiences in order to generate revenues from advertisements displayed together with the content, which are posted on digital content,
marketing and advertising platforms. These technological tools enable advertisers and website owners to earn more from their advertising
campaigns and generate additional profits from their sites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Through
its Search Platform, the Company provides services to leading search engines worldwide (&ldquo;Search Engines&rdquo;) by developing,
marketing and distributing software products to internet users. The operations and activity on this platform are powered by Gix Media.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Through
the Content Platform, the Company provides editing and marketing services of content in different languages and to different target audiences
with the goal of generating revenues from advertising employed in such content, which is posted on digital content marketing and advertising
platforms. The operations and activity on this platform are powered by Cortex.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
June 2025, we announced that our board of directors resolved to initiate a process to identify and explore potential new business opportunities,
investments and activities in a variety of new sectors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="font-size: 10pt; padding: 5pt; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Recent Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>June
2024 Facility Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 22, 2024, we entered into an amended and restated facility agreement (the &ldquo;June 2024 Facility Agreement&rdquo;) for a $1 million
(the &ldquo;June 2024 Facility Loan Amount&rdquo;) credit facility (the &ldquo;June 2024 Credit Facility&rdquo;) with certain lenders
set forth therein (the &ldquo;June 2024 Lenders&rdquo;) that amends and restates the prior facility agreement entered into on June 18,
2024 between the Company and the June 2024 Lenders (the &ldquo;Prior June 2024 Facility Agreement&rdquo;). In addition to the June 2024
Facility Loan Amount, the June 2024 Facility Agreement contemplates the inclusion of an additional $530,657 of outstanding debt owed
by us to the June 2024 Lenders (the &ldquo;June 2024 Prior Loan Amount&rdquo;, and together with the June 2024 Facility Loan Amount,
the &ldquo;June 2024 Loan Amount&rdquo;), which June 2024 Prior Loan Amount is entitled to certain rights under the June 2024 Credit
Facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
term (the &ldquo;June 2024 Facility Term&rdquo;) of the June 2024 Credit Facility expires 12 months following the date of the June 2024
Facility Agreement (the &ldquo;Initial Maturity Date&rdquo;), provided that, if the effectiveness of an uplisting of our shares of common
stock to a national securities exchange (the &ldquo;Uplist&rdquo;) occurs prior to the Initial Maturity Date, the June 2024 Facility
Term shall expire 12 months following the effective date of the Uplist. On June 5, 2025, we completed the Uplist. The June 2024 Facility
Agreement sets forth a drawdown schedule as follows: (i) an aggregate of $350,000 was drawn down on the date of the Prior June 2024 Facility
Agreement, (ii) an aggregate of $150,000 was drawn down in July 2024 upon the filing of a resale registration statement registering certain
securities issued or issuable in connection with the June 2024 Facility Agreement and (iii) an aggregate of $500,000 was drawn down upon
the effectiveness of the Uplist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
June 2024 Credit Facility accrues interest at a rate of 12% per annum, and we will also pay such interest on the June 2024 Prior Loan
Amount, which is equal to $183,679 (the &ldquo;June 2024 Facility Interest&rdquo;). The June 2024 Facility Interest was paid in advance
for the first year of the June 2024 Facility in (i) shares of our common stock at a conversion rate of $1.00 for each U.S. dollar of
June 2024 Facility Interest accrued on the respective June 2024 Loan Amount, equal to an aggregate of 183,679 shares of common stock
(the &ldquo;June 2024 Facility Shares&rdquo;) and (b) a warrant to purchase a number of shares of common stock equal to the June 2024
Facility Shares (the &ldquo;June 2024 Facility Warrant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Immediately
following the effectiveness of the Uplist, (i) $662,957 of the June 2024 Loan Amount was converted into shares of common stock at a conversion
rate equal to $1.00 per share of our common stock (the &ldquo;June 2024 Convertible Stock&rdquo;) and (ii) we issued a warrant in substantially
the same form and on substantially the same terms as a June 2024 Facility Warrant to purchase a number of shares of our common stock
equal to the June 2024 Convertible Stock with an exercise price of $1.00 per share (the &ldquo;June 2024 Conversion Warrant&rdquo;, and
(i) and (ii), collectively a &ldquo;June 2024 Conversion Unit&rdquo;). Such portion of the June 2024 Loan Amount that was not converted
into a June 2024 Conversion Unit remains outstanding and will not convert following the Uplist. For the duration of the June 2024 Facility
Term of the June 2024 Credit Facility, the June 2024 Lenders may elect to convert such unconverted portion of the June 2024 Loan Amount
into additional June 2024 Conversion Units or, upon the expiration of the June 2024 Facility Term, such unconverted portion of the June
2024 Loan Amount will be repaid in accordance with the terms of the June 2024 Facility Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="font-size: 10pt; padding: 5pt; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
June 2024 Facility Warrants are exercisable upon issuance at an exercise price of $1.00 per share of common stock, subject to certain
beneficial ownership limitations and price adjustments set forth therein, and will have a three-year term from the issuance date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
addition and in connection with the June 2024 Credit Facility, we agreed to pay L.I.A. Pure Capital Ltd. (the &ldquo;June 2024 Lead Lender&rdquo;)
a commission consisting of (i) 50,000 shares of common stock, (ii) a warrant in substantially the same form and on substantially the
same terms as the June 2024 Facility Warrant to purchase 50,000 shares of common stock with an exercise price of $1.00 per share (the
&ldquo;June 2024 Lead Lender Warrant&rdquo;) and (iii) a warrant to purchase 625,000 shares of common stock with an exercise price of
$4.00 per share, representing an aggregate exercise amount of $2.5 million, subject to beneficial ownership limitations and adjustments
(the &ldquo;June 2024 Lead Lender Fee Warrant&rdquo; and together with the June 2024 Lead Lender Warrant and the June 2024 Facility Warrants,
the &ldquo;June 2024 Warrants&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
June 2024 Lead Lender Fee Warrant was immediately exercisable upon issuance and has a three-year term from the issuance date. Following
the closing of a private placement that we entered into in July 2024, or the Private Placement, the exercise price of the June 2024 Lead
Lender Fee Warrant was adjusted to $0.472, which is the effective price per share of common stock in the Private Placement, or the June
2024 Lead Lender Fee Warrant Adjusted Exercise Price, and the number of shares of common stock issuable upon the exercise of the June
2024 Lead Lender Fee Warrant was also adjusted to a total 5,296,610 shares, or the June 2024 Lead Lender Fee Warrant Adjusted Shares,
such that the product of the June 2024 Lead Lender Fee Warrant Adjusted Exercise Price and the June 2024 Lead Lender Fee Warrant Adjusted
Shares is equal to an aggregate exercise amount of $2.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
agreed to file this registration statement with the SEC to register the resale by the June 2024 Lead Lender of the shares of common stock
issuable upon the exercise of the June 2024 Lead Lender Fee Warrant.<I>&nbsp;</I>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Reverse Split</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
March 14, 2025, we effected a one-for-four Reverse Split pursuant to which holders of our shares of common stock received one share of
common stock for every four shares of common stock held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Nasdaq Uplisting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
June 4, 2025, we issued a press release announcing that our shares of common stock, par value $0.0001 per share were approved for listing
on The Nasdaq Capital Market. Our shares of common stock began trading under the symbol &ldquo;VBIX&rdquo; on The Nasdaq Capital Market
on June 5, 2025. Our shares of common stock were previously quoted on the OTC Markets, Pink Tier under the symbol &ldquo;VBIX&rdquo;,
and ceased to be quoted on the OTC Markets, Pink Tier at the close of business on June 4, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Company Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Viewbix
Inc. was incorporated in the State of Delaware on August 16, 1985, under a predecessor name, The InFerGene Company (&ldquo;InFerGene
Company&rdquo;). On August 25, 1995, a wholly owned subsidiary of InFerGene Company merged with Zaxis International, Inc., an Ohio corporation,
which following such merger, the surviving entity, InFerGene Company, changed its name to Zaxis International, Inc. (&ldquo;Zaxis&rdquo;).
Our principal executive offices are located at 3 Hanehoshet St, Building B, 7th floor, Tel Aviv, Israel 6971068. Our website address
is https://view-bix.com/ and our telephone number is +972-9-774-1505. The information on our website is not part of this prospectus.
We have included our website address as a factual reference and do not intend it to be an active link to our website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="font-size: 10pt; padding: 5pt; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>THE OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 35%"><FONT STYLE="font-size: 10pt"><B>Shares of common stock currently outstanding</B></FONT></TD>
    <TD STYLE="font-size: 10pt; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 64%; text-align: justify"> <FONT STYLE="font-size: 10pt">9,212,473</FONT> <FONT STYLE="font-size: 10pt">
    shares of common stock.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Securities offered by the selling stockholder</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Up to 5,296,610 shares of our common stock, par value $0.0001 per share,
    issuable upon the exercise of warrants issued in connection a credit facility that we entered into in June 2024, as further described
    above under &ldquo;Prospectus Summary &#8212; Recent Developments &#8212; June 2024 Facility Agreement&rdquo;.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Shares of common stock to be outstanding </B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> <FONT STYLE="font-size: 10pt">14,509,083</FONT> <FONT STYLE="font-size: 10pt">
    shares of common stock, assuming the exercise of the June 2024 Lead Lender Fee Warrant.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Selling Stockholder</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">All of the shares of our common stock are being offered by the selling
    stockholder. See &ldquo;Selling Stockholder&rdquo; on page 8 of this prospectus for more information on the selling stockholder.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Use of Proceeds</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We will
        not receive any proceeds from the sale of shares of common stock included in this prospectus by the selling stockholder. All
        net proceeds from the sale of the shares of common stock covered by this prospectus will go to the selling stockholder.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We may receive
    the proceeds from any exercise of the warrants and if the holders do not exercise the warrants on a cashless basis. We intend to
    use the proceeds from the exercise of the warrants for working capital and general corporate purposes, including the repayment of
    certain outstanding debts owed by us.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">See the section
    of this prospectus titled &ldquo;Use of Proceeds.&rdquo;</FONT></P></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Risk Factors </B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Before investing in our securities, you should carefully read and consider
    the &ldquo;Risk Factors&rdquo; beginning on page 6 this prospectus.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Listing</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Our common stock is listed on the Nasdaq under the symbol &ldquo;VBIX&rdquo;.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Unless
otherwise indicated, the number of shares of common stock outstanding prior to and after this offering is based on 9,212,473 shares
of common stock outstanding as of June 18, 2025, and excludes as of such date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">5,296,610 shares of common stock issuable upon the exercise of outstanding
    June 2024 Lead Lender Fee Warrant issued in connection with the June 2024 Facility Agreement at an exercise price of $0.472;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">612,245 shares of common stock reserved for potential future issuance
    pursuant to our 2023 Stock Incentive Plan; and</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> <FONT STYLE="font-size: 10pt">1,117,579</FONT> <FONT STYLE="font-size: 10pt">
    shares of common stock issuable upon the exercise of warrants, with exercise prices ranging from $1.00 to $89.60.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Unless otherwise
indicated, all information in this prospectus assumes no exercise of the outstanding options or warrants described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_003"></A>RISK FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">An
investment in our securities involves certain risks. Before investing in our securities, you should carefully consider the risk set forth
below, as well as the risks described in our most recent Annual Report on Form 10-K, any updates to those risks in our Quarterly Reports
on Form 10-Q or Current Reports on Form 8-K, together with all of the other information appearing in this prospectus or incorporated
by reference into this prospectus. The risks so described are not the only risks facing us. Additional risks not presently known to us
or that we currently deem immaterial may also impair our business operations. Any of these risks could materially and adversely affect
our business, financial condition, results of operations and cash flows and could result in a loss of all or part of your investment.
In any case, the value of the securities offered by means of this prospectus could decline due to any of these risks, and you may lose
all or part of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>The
sale of a substantial amount of our shares of common stock including resale of the shares being registered hereunder in the public market
could adversely affect the prevailing market price of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are registering for resale 5,296,610 shares of common stock. Sales of substantial amounts of shares of our shares of common stock in
the public market, or the perception that such sales might occur, could adversely affect the market price of our shares of common stock,
and the market value of our other securities. We cannot predict if and when selling stockholder may sell such shares in the public markets.
Furthermore, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into shares
of common stock. Any such issuance could result in substantial dilution to our existing shareholders and could cause our stock price
to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt"><B><I>Conditions
in Israel, including Israel&rsquo;s conflicts with Hamas and other parties in the region, as well as political and economic instability,
may impede our ability to operate and harm our financial results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Because
all of our operations are conducted in Israel and all members of our board of directors and management as well as all of our employees
and consultants, including employees of our service providers, are located in Israel, our business and operations are directly affected
by economic, political, geopolitical and military conditions in Israel. Since the establishment of the State of Israel in 1948 and in
recent years, armed conflicts between Israel and its neighboring countries and terrorist organizations active in the region have involved
missile strikes, hostile infiltrations, terrorism against civilian targets in various parts of Israel, and recently abduction of soldiers
and citizens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Following
the October 7th attacks by Hamas terrorists in Israel&rsquo;s southern border, Israel declared war against Hamas and since then, Israel
has been involved in military conflicts with Hamas, Hezbollah, a terrorist organization based in Lebanon, and Iran, both directly and
through proxies like the Houthi movement in Yemen and armed groups in Iraq and other terrorist organizations. Additionally, following
the fall of the Assad regime in Syria, Israel has conducted limited military operations targeting the Syrian army, Iranian military assets
and infrastructure linked to Hezbollah and other Iran-supported groups. Although certain ceasefire agreements have been reached, and
some Iranian proxies have declared a halt to their attacks, there is no assurance that these agreements will be upheld, military activity
and hostilities continue to exist at varying levels of intensity, and the situation remains volatile, with the potential for escalation
into a broader regional conflict involving additional terrorist organizations and possibly other countries. In June 2025, a new round
of direct hostilities broke out between Israel and Iran, involving significant missile and drone strikes exchanged between the two countries.
This escalation has heightened regional instability, increased security risks across Israel,  resulted in significant travel restrictions,
facility closures and shelter-in-place orders, including remote work measures, in various locations, and may further impact critical
infrastructure, supply chains, and the broader Israeli economy. Also, the fall of the Assad regime in Syria may create geopolitical instability
in the region.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">While
our facilities have not been damaged during the current war, the hostilities with Hamas, Hezbollah, Iran and its proxies and others have
caused and may continue to cause damage to private and public facilities, infrastructure, utilities, and telecommunication networks,
and potentially disrupting our operations and supply chains. In addition, Israeli organizations, government agencies and companies have
been subject to extensive cyber attacks. This could lead to increased costs, risks to employee safety, and challenges to business continuity,
with potential financial losses. The continuation of the war has also led to a deterioration of certain indicators of Israel&rsquo;s
economic standing, for instance, a downgrade in Israel&rsquo;s credit rating by rating agencies (such as by Moody&rsquo;s, S&amp;P Global,
and Fitch).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with the ongoing war, several hundred thousand Israeli military reservists were drafted to perform immediate military service,
and military reservists are expected to perform long reserve duty service in the coming years. As of date of this prospectus, none of
our employees or consultants in Israel have been called to reserve duty and there has been no material impact on our business from past
reserve services. However, certain of our employees and consultants in Israel, in addition to employees of our service providers located
in Israel, may be called, for service in the current or future wars or other armed conflicts with Hamas, as well as the other pending
or future armed conflicts in which Israel is or may become engaged, and such persons may be absent for an extended period of time. As
a result, our operations may be disrupted by such absences, which disruption may materially and adversely affect our business, prospects,
financial condition and results of operations. Additionally, the absence of employees of our Israeli suppliers and contract manufacturers
due to their military service in the current or future wars or other armed conflicts may disrupt their operations, which in turn may
materially and adversely affect our ability to deliver or provide products and services to customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli
government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot
assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages
incurred by us could have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt">The
global perception of Israel and Israeli companies, influenced by actions by international judicial bodies, may lead to increased sanctions
and other negative measures against Israel, as well as Israeli companies and academic institutions. There is also a growing movement
among countries, activists, and organizations to boycott Israeli goods, services and academic research or restrict business with Israel,
which could affect business operations. If these efforts become widespread, along with any future rulings from international tribunals
against Israel, they could significantly and negatively impact business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">As
of the date of this prospectus, the Company&rsquo;s revenues have not been directly negatively affected by the ongoing hostilities in
the region, as the primary source of its revenues is predominantly from the U.S. or European markets, that have been not significantly
impacted by the ongoing hostilities in Israel. As a result, as of the date of this prospectus the Company&rsquo;s abilities to deliver
or provide products and services to its customers have not been materially affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Finally,
prior to the October 2023 war, the Israeli government pursued changes to Israel&rsquo;s judicial system and has recently renewed its
efforts to effect such changes. In response to the foregoing developments, certain individuals, organizations, and institutions, both
within and outside of Israel, voiced concerns that such proposed changes, if adopted, may negatively impact the business environment
in Israel. Such proposed changes may also lead to political instability or civil unrest. If such changes to Israel&rsquo;s judicial system
are pursued by the government and approved by the parliament, this may have an adverse effect on our business, results of operations,
and ability to raise additional funds, if deemed necessary by our management and board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>Some
of our employees are obligated to perform military reserve duty in Israel.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Many
Israeli citizens, including our employees are obligated to perform one month, and in some cases more, of annual military reserve duty
until they reach the age of 40 (or older, for reservists with certain occupations) and, in the event of a military conflict, may be called
to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists.
It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups. Such
disruption could materially adversely affect our business, results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_004"></A>SPECIAL NOTE
REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
prospectus includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The Company has based these forward-looking statements on its current expectations
and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions
about the Company that may cause its actual results, levels of activity, performance or achievements to be materially different from
any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some
cases, you can identify forward-looking statements by terminology such as &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;,
&ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;expect&rdquo;, &ldquo;plan&rdquo;, &ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;,
&ldquo;estimate&rdquo;, &ldquo;continue&rdquo;, or the negative of such terms or other similar expressions. Forward-looking statements
are based on information we have when those statements are made or our management&rsquo;s good faith belief as of that time with respect
to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from
those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are
not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the continued demand of digital advertising as an integral part of
    corporate marketing and internal communications plans and the continued growth and acceptance of digital advertising as effective
    alternatives to traditional offline marketing products and service;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to retain and attract a programmatic advertiser, and the
    associated payments received from such programmatic advertisers&rsquo; ads on websites which have been categorized as &ldquo;Made
    for Advertising&rdquo;;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to generate enough cash flow to meet our debt obligations
    or fund our other liquidity needs, and substantial doubt regarding our ability to continue as a going concern;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our need to raise additional capital to meet our business requirements
    in the future and such capital raising may be costly or difficult to obtain and could dilute out shareholders&rsquo; ownership interests;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to receive credit facility to fund our operations, at favorable
    terms, or at all;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to pay our obligations when they become due, including
    the contemplated debt restructuring program currently under negotiation with our credit and debtholders;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our subsidiaries&rsquo; future performance, including our ability to
    instill potential measures to assist Cortex and Gix Media in mitigating future economic harm;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">entry of new competitors and products, the impact of large and established
    internet and technology companies and potential technological obsolescence of our offered platforms; and</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">political, economic and military conditions in Israel, including the
    current security situation in Israel, as well as the war&rsquo;s potential impact on our business and operation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or
risk factors that we are faced with which may cause our actual results to differ from those anticipated in our forward-looking statements.
For a discussion of these and other risks that relate to our business and investing in our common stock, you should carefully review
the risks and uncertainties described in this prospectus and in the Company&rsquo;s other Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
filings. The Company&rsquo;s actual results could differ materially from those contemplated in these forward-looking statements as a
result of these factors. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances
occurring after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_005"></A>USE OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
will not receive any proceeds from the sale of the shares of common stock by the selling stockholder. All net proceeds from the sale
of the shares of common stock covered by this prospectus will go to the selling stockholder. We expect that the selling stockholder will
sell its shares of common stock as described under &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
may receive proceeds from the exercise of the warrants and issuance of the underlying warrant shares to the extent that these warrants
are exercised for cash. The warrants, however, are exercisable on a cashless basis under certain circumstances. If all of the warrants
mentioned above were exercised for cash in full, the proceeds would be approximately $2.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
intend to use the net proceeds of such warrant exercises, if any, for general corporate purposes and working capital, including the repayment
of certain outstanding debts owed by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pending
any use, as described above, we intend to invest the net proceeds in high-quality, short-term, interest-bearing securities. We can make
no assurances that any of the warrants will be exercised, or if exercised, that they will be exercised for cash, the quantity which will
be exercised or in the period in which they will be exercised. As of the date of this prospectus, we cannot specify with certainty all
of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. Accordingly, we will
retain broad discretion over the use of these proceeds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_006"></A>SELLING STOCKHOLDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
shares of common stock being offered by the selling stockholder are those shares of common stock issuable upon exercise of the warrants
previously issued in in connection with the June 2024 Facility Agreement. For additional information regarding the issuance of those
warrants, see &ldquo;Prospectus Summary &#8212; Recent Developments &#8212; June 2024 Facility Agreement&rdquo; above. We are registering
the shares of common stock in order to permit the selling stockholder to offer the shares of common stock for resale from time to time.
Except for the ownership of the shares of common stock and the warrants issued the Private Placement, the selling stockholder has not
had any material relationship with us within the past three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
table below lists the selling stockholder and other information regarding the beneficial ownership of the shares of common stock by the
selling stockholder. The second column lists the number the shares of common stock beneficially owned by the selling stockholder, based
on its ownership of the shares of common stock, as of June 18, 2025, assuming exercise of the warrants held by the selling stockholder
on that date, without regard to any limitations on conversions or exercises. The third column lists the maximum number of the shares
of common stock being offered in this prospectus by the selling stockholder. The fourth and fifth columns list the amount of the shares
of common stock owned after the offering, by number of the shares of common stock and percentage of outstanding the shares of common
stock (assuming for the purpose of such percentage, 9,212,473 shares outstanding as of June 18, 2025) assuming in both
cases the sale of all of the shares of common stock offered by the selling stockholder pursuant to this prospectus, and without regard
to any limitations on conversions or exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Under
the terms of the warrants, the selling stockholder may not exercise the warrants to the extent such exercise would cause such selling
stockholder, together with its affiliates, to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%,
as applicable, of our then outstanding shares of common stock following such exercise, excluding for purposes of such determination shares
of common stock not yet issuable upon exercise of the warrants and placement agent warrants which have not been exercised. The number
of shares does not reflect this limitation. The selling stockholder may sell all, some or none of their shares of common stock or Warrants
in this offering. See &ldquo;Plan of Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">Selling Stockholder</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares
                                            of<BR> Common<BR> Stock Owned<BR> Prior to<BR> Offering#</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Maximum<BR>
    Number of<BR> Shares of<BR> Common<BR> Stock to be<BR> Sold Pursuant <BR> to this<BR> Prospectus</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Number
    <BR> of Shares<BR> of<BR> Common<BR> Stock<BR> Owned<BR> After the<BR> Offering</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">Percentage<BR>
    of Shares<BR> of <BR> Common<BR> Stock<BR> Owned<BR> After the<BR> Offering</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">L.I.A. Pure Capital Ltd. (1)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 10pt">6,469,329</FONT> </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">5,296,610</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 10pt">1,172,719</FONT> </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">4.99</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">#</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Beneficial ownership is determined in accordance with
    SEC rules and generally includes voting or investment power with respect to securities. Shares of common stock subject to options
    or warrants currently exercisable, or exercisable within 60 days of June 18, 2025, are counted as outstanding for computing
    the percentage of the selling stockholder holding such options or warrants but are not counted as outstanding for computing the percentage
    of any other selling stockholder.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Kfir Silberman is the officer, sole director, chairman of the board
    of directors and controlling shareholder of L.I.A. Pure Capital Ltd., and its address is 20 Raoul Wallenberg Street, Tel Aviv, Israel
    6971916.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Consists of (i) 615,585 shares of common stock
    and (ii) 5,853,744 shares of common stock issuable upon the exercise of warrants (including 5,296,610 shares of common stock issuable
    upon the exercise of the June 2024 Lead Lender Fee Warrant registered on the registration statement pursuant to which this prospectus
    relates). All of the warrants have a blocker provision that subject the exercise/conversion of such securities to a 4.99% beneficial
    ownership limitation. If the foregoing securities did not contain such beneficial ownership limitation, the selling stockholder would
    have beneficially owned approximately 42.94% of our outstanding shares of common stock prior to this offering.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Consists of 5,296,610 shares of common of stock issuable upon exercise
    of the June 2024 Lead Lender Fee Warrant.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Consists of (i) 615,585 shares of common stock
    and (ii) 557,134 shares of common stock issuable upon the exercise of warrants. All of the warrants have a blocker provision that
    subject the exercise/conversion of such securities to a 4.99% beneficial ownership limitation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_007"></A>PLAN OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
selling stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any
or all of their securities covered hereby on the Nasdaq or any other stock exchange, market or trading facility on which the securities
are traded or in private transactions. These sales may be at fixed or negotiated prices The selling stockholder may use any one or more
of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer
    solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">block trades in which the broker dealer will attempt to sell the securities
    as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer
    for its account;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">an exchange distribution in accordance with the rules of the applicable
    exchange;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">settlement of short sales;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">in transactions through broker-dealers that agree with the selling
    stockholder to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">through the writing or settlement of options or other hedging transactions,
    whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
selling stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available,
rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Broker-dealers
engaged by the selling stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the selling stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with the sale of the securities or interests therein, the selling stockholder may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The selling stockholder may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholder may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
selling stockholder and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed us that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are required to pay certain fees and expenses incurred by us incident to the registration of the securities. We have agreed to indemnify
the selling stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the selling stockholder
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
us to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect
or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar
effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state
securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the selling stockholder will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common
stock by the selling stockholder or any other person. We will make copies of this prospectus available to the selling stockholder and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_008"></A>DESCRIPTION OF
THE OFFERED SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
authorized capital stock consists of 500,000,000 shares of which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">490,000,000 shares are designated as common stock with a par value of $0.0001; and</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10,000,000 shares are designated as preferred stock with a par value of $0.0001.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Holders
of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative
voting rights. An election of directors by our stockholders shall be determined by a plurality of the votes cast by the stockholders
entitled to vote on the election. Holders of common stock are entitled to receive proportionately any dividends as may be declared by
our board of directors, subject to any preferential dividend rights of any series of preferred stock that we may designate and issue
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
the event of our liquidation or dissolution, the holders of common stock are entitled to receive proportionately our net assets available
for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any outstanding
preferred stock. Holders of common stock have no preemptive, subscription, redemption or conversion rights. Our outstanding shares of
common stock are validly issued, fully paid and nonassessable. The rights, preferences and privileges of holders of common stock are
subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate
and issue in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
connection with the Reorganization Transaction (as such term is defined in our Annual Report on Form 10-K), we filed our Certificate
of Incorporation with the Secretary of State of Delaware, effective as of August 31, 2022, pursuant to which we, among other things,
effected a reverse stock split of our common stock at a ratio of 1-for-28.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
March 14, 2025, we effected a one-for-four Reverse Split pursuant to which holders of our shares of common stock received one share of
common stock for every four shares of common stock held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Under
the terms of our Certificate of Incorporation, our board of directors is authorized to direct us to issue shares of preferred stock in
one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges
and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of
each series of preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays
associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third-party
to acquire, or could discourage a third-party from seeking to acquire, a majority of our outstanding voting stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Anti-Takeover
Provisions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>No
Cumulative voting</I>. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the voting
power of our shares of common stock outstanding are able to elect all of our directors. Our Certificate of Incorporation and Bylaws provide
that all stockholder actions must be effected at a duly called meeting of stockholders, and for so long as our common stock is not approved
for listing on the Nasdaq Stock Market LLC, any stockholder action may be effected by written consent in lieu of a meeting. A special
meeting of stockholders may be called only by a majority of our board of directors, the chairperson of our board of directors, or our
chief executive officer or our president.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Amendment
of Charter Provisions</I>. Our Certificate of Incorporation further provides that the affirmative vote of holders of at least sixty-six
and two-thirds percent (66-2/3%) of the voting power of all of the total voting power, voting together as a single class, is required
to amend certain provisions of our Certificate of Incorporation, including provisions relating to the issuance of preferred stock, the
size and classes of the board of directors, removal of directors, stockholder meetings, directors&rsquo; liabilities director indemnification
and forum selection. The affirmative vote of holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all
of the then outstanding shares of voting stock, voting as a single class, is required to amend or repeal certain articles of our Certificate
of Incorporation. Our Bylaws, may be amended by a simple majority vote of our board of directors, or by an affirmative vote of holders
of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then outstanding shares of voting stock, voting
as a single class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Staggered
Board</I>. Our Certificate of Incorporation and Bylaws further provides that our board of directors is divided into three classes, Class
I, Class II and Class III, with each class serving staggered terms, and give our board of directors the exclusive right to expand the
size of our board of directors and to elect directors to fill a vacancy created by the expansion of the board of directors or the resignation,
death or removal of a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Special
Meetings of Stockholders</I>. Our Certificate of Incorporation currently provides that special meetings of our stockholders may be called
by our chairperson of our board of directors, chief executive officer, president or by the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Exclusive
Forum Provision</I>. Our Certificate of Incorporation provide that, unless we consent in writing to the selection of an alternative forum,
to the fullest extent permitted by law, the Court of Chancery of the State of Delaware is the sole and exclusive forum for: (i) any derivative
action or proceeding brought on behalf of us; (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors,
officers or other employees or agents to us or our stockholders; (iii) any action asserting a claim against us arising pursuant to any
provision of the DGCL or our Certificate of Incorporation or Bylaws; or as to which the DGCL of the State of Delaware confers jurisdiction
to the Court of Chancery of the State of Delaware, or (iv) any action asserting a claim against us governed by the internal affairs doctrine;
and subject to the federal district courts of the United States of America being the exclusive forum for the resolution of any complaint
asserting a cause or causes of action arising under the Securities Act of 1933, as amended and by the Exchange Act of 1934, or any other
claim for which the federal courts have exclusive jurisdiction.. Under the Securities Act, federal and state courts have concurrent jurisdiction
over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the
federal securities laws and the rules and regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce
such a forum selection provision as written in connection with claims arising under the Securities Act. The enforceability of similar
choice of forum provisions in other companies&rsquo; certificates of incorporation has been challenged in legal proceedings, and it is
possible that, in connection with any action, a future court could find the choice of forum provisions contained in our Certificate of
Incorporation to be inapplicable or unenforceable in such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Issuance
of undesignated Preferred Stock</I>. Our board of directors has the authority, without further action by the stockholders, to issue up
to 10,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time
by our board of directors. The existence of authorized but unissued shares of preferred stock, which may be converted into large numbers
of shares of Common Stock, would enable our board of directors to render more difficult or to discourage an attempt to obtain control
of us by means of a merger, tender offer, proxy contest or other means</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
foregoing provisions will make it more difficult for our existing stockholders to replace our board of directors as well as for another
party to obtain control of our company by replacing our board of directors. Since our board of directors has the power to retain and
discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change
in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to issue preferred
stock with voting or other rights or preferences that could impede the success of any attempt to change the control of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">These
provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies
and to discourage certain types of transactions that may involve an actual or threatened acquisition of our company. These provisions
are also designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage certain tactics that may be used
in proxy rights. However, these provisions could have the effect of discouraging others from making tender offers for our shares and
may have the effect of deterring hostile takeovers or delaying changes in control of our company or our management. As a consequence,
these provisions also may inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Section 203
of the Delaware General Corporation Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are subject to Section 203 of the DGCL, which prohibits a publicly-held Delaware corporation from engaging in any business combination
with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with
the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">before such date, our board of directors approved either the business
    combination or the transaction that resulted in the stockholder becoming an interested stockholder;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">upon closing of the transaction that resulted in the stockholder becoming
    an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the
    time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock
    owned by the interested stockholder) those shares owned by (1) persons who are directors and also officers and (2) employee stock
    plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will
    be tendered in a tender or exchange offer; or</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">on or after such date, the business combination is approved by our
    board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative
    vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.</FONT></TD></TR>

<TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 24px; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">In general, Section 203 defines business combination
    to include the following:</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any merger or consolidation involving the corporation
    and the interested stockholder;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 24px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any sale, transfer, pledge or other disposition of
    10% or more of the assets of the corporation involving the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">subject to certain exceptions, any transaction that results in the
    issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">any transaction involving the corporation that has the effect of increasing
    the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder;
    or</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the receipt by the interested stockholder of the benefit of any loss,
    advances, guarantees, pledges or other financial benefits by or through the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In
general, Section 203 defines an &ldquo;interested stockholder&rdquo; as an entity or person who, together with the person&rsquo;s affiliates
and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own,
15% or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Limitations
on Liability and Indemnification Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that we may indemnify each of our directors and executive officers to the fullest extent
permitted by the DGCL. We have entered into indemnification agreements with each of our directors and executive officers that may, in
some cases, be broader than the specific indemnification provisions contained under Delaware law. Further, pursuant to our indemnification
agreements and directors&rsquo; and officers&rsquo; liability insurance, our directors and executive officers are indemnified and insured
against the cost of defense, settlement or payment of a judgment under certain circumstances. In addition, as permitted by Delaware law,
our Certificate of Incorporation includes provisions that eliminate the personal liability of our directors for monetary damages resulting
from breaches of certain fiduciary duties as a director. The effect of this provision is to restrict our rights and the rights of our
stockholders in derivative suits to recover monetary damages against a director for breach of fiduciary duties as a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">These
provisions may be held not to be enforceable for violations of the federal securities laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
common stock is listed on the Nasdaq under the symbol &ldquo;VBIX&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Transfer Agent
and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
transfer agent and registrar for our common stock is Transfer Online. The transfer agent and registrar&rsquo;s address is 512 SE Salmon
Street, Portland, OR 97214-3444. The transfer agent&rsquo;s telephone number is (503) 227-2950.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_009"></A>LEGAL MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
validity of the shares of common stock offered hereby will be passed upon for us by Greenberg Traurig, P.A., Tel Aviv, Israel. If the
securities are distributed in an underwritten offering, certain legal matters will be passed upon for the underwriters by counsel identified
in the applicable prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_010"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
consolidated financial statements of Viewbix Inc. as of December 31, 2024 and 2023, and for each of the two years in the period ended
December 31, 2024, incorporated by reference into this prospectus and into the registration statement of which it forms a part, have
been audited by Brightman Almagor Zohar &amp; Co., a Firm in the Deloitte Global Network, an independent registered public accounting
firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm given
their authority as experts in accounting and auditing. The audit report covering the consolidated financial statements <FONT STYLE="font-family: Times New Roman, Times, Serif">as
of</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif"> </FONT> December 31, 2024 and 2023, and for each of the two years
in the period ended December 31, 2024 contains an explanatory paragraph describing conditions that
raise substantial doubt about the Company&rsquo;s ability to continue as a going concern as described in Note 1G to the consolidated
financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_011"></A>WHERE YOU CAN
FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
are subject to the informational requirements of the Exchange Act and in accordance therewith file annual, quarterly and current reports,
proxy statements and other information with the SEC. Such reports, proxy statements and other information can be read and copied at the
SEC&rsquo;s public reference facilities at 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates. Please call the SEC at 1-800-732-0330
for further information on the operation of the public reference facilities. In addition, the SEC maintains a website that contains reports,
proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of the
SEC&rsquo;s website is www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
make available free of charge on or through our website at www.view-bix.com, our Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange
Act as soon as reasonably practicable after we electronically file such material with or otherwise furnish it to the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have filed with the SEC a registration statement under the Securities Act, relating to the securities offered under this prospectus.
The registration statement, including the attached exhibits, contains additional relevant information about us and the securities. This
prospectus does not contain all of the information set forth in the registration statement. You can obtain a copy of the registration
statement, at prescribed rates, from the SEC at the address listed above, or for free at www.sec.gov. The registration statement and
the documents referred to below under &ldquo;Incorporation of Certain Information by Reference&rdquo; are also available on our website,
www. view-bix.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
have not incorporated by reference into this prospectus the information on our website, and you should not consider it to be a part of
this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_012"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
SEC allows us to &ldquo;incorporate by reference&rdquo; the information we have filed with it, which means that we can disclose important
information to you by referring you to those documents. The information we incorporate by reference is an important part of this prospectus,
and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference
the documents listed below and any future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we
file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this prospectus and prior
to the termination of the offering:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315225011100/form10-k.htm">Form 10-K</A> for the fiscal year ended December 31,
    2024, filed with the SEC on March 21, 2025;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Our Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225010059/form10-q.htm">Form 10-Q</A> for the quarter ended March 31, 2025,
    filed with the SEC on May 14, 2025; </FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Our Current Reports on Form 8-K (other than portions thereof furnished
    under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that relate to such items), filed with the SEC on
    the following dates: <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315225005175/form8-k.htm">February 6, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315225010229/form8-k.htm">March 13, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225000368/form8-k.htm">March 24, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225001491/form8-k.htm">March 31, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225013644/form8-k.htm">June 4, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225014311/form8-ka.htm">June 9, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225014584/form8-k.htm">June 11, 2025</A>;
    and </FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The description of our common stock, which is contained in our Annual
    Report on <A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315225011100/form10-k.htm">Form 10-K</A> for the fiscal year ended December 31, 2024, filed with the SEC on March 21, 2025, and as may be further updated
    or amended in any amendment or report filed for such purpose.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Notwithstanding
the foregoing, information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, is
not incorporated by reference in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
information about us contained in this prospectus should be read together with the information in the documents incorporated by reference.
You may request a copy of any or all of these filings, at no cost, by writing or telephoning us at: Amihay Hadad, Chief Executive Officer,
3 Hanehoshet St, Building B, 7th floor, Tel Aviv, Israel, 6971068, telephone number +972 9-774-1505.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>5,296,610
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><IMG SRC="image_002.jpg" ALT="" STYLE="width: 235px; height: 46px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Viewbix
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>,
2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>PART II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>INFORMATION NOT
REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Item 13. Other
Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
following are the estimated expenses related to the filing of the registration statement of which this prospectus forms a part, all of
which will be paid by us. With the exception of the SEC registration fee, all amounts are estimates and may change:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">SEC Registration Fee</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 10pt">3,208</FONT> </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Accounting Fees and Expenses</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">10,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Legal Fees and Expenses</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 10pt">35,000</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Miscellaneous Fees and Other Expenses</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">10,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Total</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"> <FONT STYLE="font-size: 10pt">58,208</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Item 14. Indemnification
of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Section
145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees
and individuals against expenses including attorneys&rsquo; fees, judgments, fines and amounts paid in settlement in connection with
various actions, suits or proceedings, whether civil, criminal, administrative or investigative other than an action by or in the right
of the corporation, a derivative action, if they acted in good faith and in a manner they reasonably believed to be in or not opposed
to the best interests of the corporation, and, with respect to any criminal action or proceeding, if they had no reasonable cause to
believe their conduct was unlawful. A similar standard is applicable in the case of derivative actions, except that indemnification only
extends to expenses including attorneys&rsquo; fees incurred in connection with the defense or settlement of such actions, and the statute
requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the
corporation. The statute provides that it is not exclusive of other indemnification that may be granted by a corporation&rsquo;s certificate
of incorporation, bylaws, agreement, a vote of stockholders or disinterested directors or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that we will indemnify and hold harmless, to the fullest extent permitted by Section
145 of the Delaware General Corporation Law, as amended from time to time, each person that such section grants us the power to indemnify.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation
shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director,
except for liability for:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">any breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">acts or omissions not in good faith or which involve intentional misconduct or a knowing violation
    of law;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">payments of unlawful dividends or unlawful stock repurchases or redemptions; or</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">any transaction from which the director derived an improper personal benefit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, offices or controlling persons of
ours, pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the Securities and Exchange Commission,
such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid by a director, officer
or controlling person of ours in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered hereunder, we will, unless in the opinion of our counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Item 15. Recent
Sales of Unregistered Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
sold the securities described below within the past three years which were not registered under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-size: 10pt">Since January 1,
2022, we have issued an aggregate of 27,778 shares of common stock to our employees, officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt"><FONT STYLE="font-size: 10pt">Since
January 1, 2022, we have granted our directors, officers and employees RSUs to purchase an aggregate of 12,756 shares of our common stock,
under our 2023 Stock Incentive Plan. As of June 18, 2025, we did not have any options to purchase shares of our common stock granted
to our directors, officers and employees remain outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
November 15, 2023, our Israeli subsidiary, Viewbix Ltd. (&ldquo;Viewbix Israel&rdquo;) entered into a Loan Agreement (the &ldquo;2023
Loan&rdquo;) with certain lenders (the &ldquo;Lenders&rdquo;) whereby the Lenders provided Viewbix Israel with loans in the aggregate
amount of $480,000 (which sum may be increased to up to $1,000,000, at the discretion of the Lenders). In connection with the 2023 Loan,
the Company issued to each Lender a warrant to purchase shares of the Company&rsquo;s common stock (the &ldquo;2023 Warrants&rdquo;),
such that the number of shares of common stock underlying each 2023 Warrant will reflect (one-for-one) the number of dollars provided
by each Lender as part of the principal amount. Each 2023 Warrant has an exercise price per share of common stock of $2.00 and will expire
and cease to be exercisable on December 31, 2025. The 2023 Warrants were issued to the Lenders pursuant to Regulation S of the Securities
Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 3, 2024, we entered into a definitive securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with a global investment
firm (the &ldquo;Lead Investor&rdquo;) for the purchase and sale in a private placement (the &ldquo;Private Placement&rdquo;) of units
(the &ldquo;Units&rdquo;) consisting of (i) 256,875 shares of our common stock and (ii) common stock purchase warrants to purchase up
to 385,313 shares of our common stock to the Lead Investor and other investors acceptable to the Lead Investor and us. The purchase price
per Unit was $1.00. Upon the closing of the Private Placement, we reimbursed the Lead Investor $10,000 for actual and documented fees
and expenses incurred. In addition, we paid a commission to the Lead Investor of (i) a cash fee of $12,844 and (ii) 12,844 shares of
our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 22, 2024, we entered into an amended and restated facility agreement for a $1 million credit facility (the &ldquo;June 2024 Credit
Facility&rdquo;) with certain lenders set forth therein. Interest of the June 2024 Credit Facility was paid in (i) shares of our common
stock at a conversion rate of $1.00 for each U.S. dollar of June 2024 Facility Interest accrued on the respective June 2024 Loan Amount,
equal to an aggregate of 183,680 shares of common stock (the &ldquo;June 2024 Facility Shares&rdquo;) and (b) a warrant to purchase a
number of shares of common stock equal to the June 2024 Facility Shares (the &ldquo;June 2024 Facility Warrant&rdquo;). In addition and
in connection with the June 2024 Credit Facility, we agreed to pay L.I.A. Pure Capital Ltd. a commission consisting of (i) 50,000 shares
of common stock, (ii) a warrant to purchase 50,000 shares of common stock with an exercise price of $1.00 per share, in substantially
the same form and on substantially the same terms as the June 2024 Facility Warrant and (iii) a warrant to purchase 625,000 shares of
common stock with an exercise price of $4.00 per share (the &ldquo;June 2024 Lead Lender Fee Warrant&rdquo;), subject to beneficial ownership
limitations and adjustments. Following the closing of the Private Placement, the exercise price of the June 2024 Lead Lender Fee Warrant
was adjusted to $0.472, which is the effective price per share of common stock in the Private Placement, or the June 2024 Lead Lender
Fee Warrant Adjusted Exercise Price, and the number of shares of common stock issuable upon the exercise of the June 2024 Lead Lender
Fee Warrant was also adjusted to a total 5,296,610 shares, or the June 2024 Lead Lender Fee Warrant Adjusted Shares, such that the product
of the June 2024 Lead Lender Fee Warrant Adjusted Exercise Price and the June 2024 Lead Lender Fee Warrant Adjusted Shares is equal to
an aggregate exercise amount of $2.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 22, 2024, we entered into an amended and restated facility agreement for a $2.5 million (the &ldquo;First July 2024 Facility Loan
Amount&rdquo;) credit facility (the &ldquo;First July 2024 Credit Facility&rdquo;) with a certain lender (the &ldquo;First July 2024
Lender&rdquo;). Interest of the First July 2024 Credit Facility was paid in (i) 300,000 shares of our common stock at a conversion rate
of $1.00 for each U.S. dollar of First July 2024 Facility Interest accrued on the respective First July 2024 Facility Loan Amount, and
(ii) a warrant to purchase 300,000 shares of our common stock at a conversion rate of $1.00 for each U.S. dollar of First July 2024 Facility
Interest accrued on the respective First July 2024 Facility Loan Amount. In addition and in connection with the First July 2024 Credit
Facility, we agreed to pay the First July 2024 Lender a one-time fee consisting of: (i) 125,000 shares of our common stock, representing
five percent (5%) of the First July 2024 Facility Loan Amount at a conversion rate of $1.00 and (ii) a warrant to purchase 250,000 shares
of our common stock with an exercise price of $1.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 28, 2024, we entered into a facility agreement for a $3.0 million (the &ldquo;Second July 2024 Facility Loan Amount&rdquo;) credit
facility (the &ldquo;Second July 2024 Credit Facility&rdquo;) with a certain lender (the &ldquo;Second July 2024 Lender&rdquo;). Interest
of the Second July 2024 Credit Facility was paid in (i) 360,000 shares of our common stock at a conversion rate of $1.00 for each U.S.
dollar of Second July 2024 Facility Interest accrued on the respective Second July 2024 Facility Loan Amount, and (ii) a warrant to purchase
360,000 shares of our common stock at a conversion rate of $1.00 for each U.S. dollar of Second July 2024 Facility Interest accrued on
the respective Second July 2024 Facility Loan Amount. In addition and in connection with the Second July 2024 Credit Facility, we agreed
to pay the Second July 2024 Lender a one-time fee consisting of 150,000 shares of our common stock, representing five percent (5%) of
the Second July 2024 Facility Loan Amount at a conversion rate of $1.00.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
July 14, 2024 and July 25, 2024, we entered into consulting agreements with certain consultants (the &ldquo;Consultants&rdquo;) pursuant
to which the Consultants agreed to provide certain services to us. As partial compensation, we agreed to issue 120,000 shares of our
common stock to the Consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
March 24, 2025, we entered into a securities exchange agreement, or the Securities Exchange Agreement, with Metagramm Sofotware Ltd.,
or Metagramm, and all of the shareholders of Metagramm, or the Metagramm Shareholders, pursuant to which we issued to the Metagramm Shareholders
an aggregate of 19.99% of our issued and outstanding capital stock on a pro rata and post-closing basis, equal to 1,323,000 shares of
our common stock, or the Exchange Shares, in exchange for 100% of Metagramm&rsquo;s issued and outstanding share capital on a fully diluted
and post-closing basis, equal to 718,520 Metagramm ordinary shares. The transactions contemplated by the Securities Exchange Agreement
closed on March 24, 2025, subject to the satisfaction of customary closing conditions. In connection with a request for a tax ruling
with the Israeli Tax Authority, the Exchange Shares shall be held in escrow for 30 days for the benefit of the Metagramm Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We
believe that the offers, sales and issuances of the securities described in the preceding paragraphs were exempt from registration either
(a) under Section 4(a)(2) of the Securities Act and the rules and regulations promulgated thereunder (including Regulation D and Rule
506), in that the transactions were between an issuer and sophisticated investors or members of its senior executive management and did
not involve any public offering within the meaning of Section 4(a)(2) or (b) under Regulation S promulgated under the Securities Act
in that offers, sales and issuances were not made to persons in the United States and no directed selling efforts were made in the United
States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Item 16. Exhibits and Financial Statement
Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt">
    <TD STYLE="font-size: 10pt; vertical-align: top; width: 0.75in; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit Number</B></FONT></TD>
    <TD STYLE="font-size: 10pt; vertical-align: top; width: 0.1in; padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description
    of Document</B></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315222025050/ex3-1.htm"><FONT STYLE="font-size: 10pt">Amended and Restated Certificate of Incorporation of Viewbix Inc. (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s current report on Form 8-K, filed with the SEC on September 6, 2022)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315222026323/ex3-2.htm"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws of Viewbix Inc. (incorporated by reference to Exhibit 3.2 to the Company&rsquo;s current report on Form 8-K, filed with the SEC on September 20, 2022)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224028474/ex3-1.htm"><FONT STYLE="font-size: 10pt">Certificate of Amendment to Certificate of Incorporation filed July 15, 2024 (incorporated by reference to Exhibit 3.1 to the Company&rsquo;s current report on Form 8-K, filed with the SEC on July 19, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315223008765/ex4-1.htm"><FONT STYLE="font-size: 10pt">Description of Registrant&rsquo;s Securities (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 24, 2023)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">5.1*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-size: 10pt">Opinion of Greenberg Traurig, P.A.</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315219011140/ex4-1.htm"><FONT STYLE="font-size: 10pt">Form of Warrant by and between the Company and Gix Media Ltd., dated July 25, 2019 (incorporated by reference to Exhibit 4.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 25, 2019)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315223044578/ex10-2.htm"><FONT STYLE="font-size: 10pt">Form of Warrant by and between the Company and the holders thereto, dated December 7, 2023 (incorporated by reference to Exhibit 10.2 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on December 12, 2023)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315218005357/ex99-1.htm"><FONT STYLE="font-size: 10pt">2017 Employee Incentive Plan (incorporated by reference to the Registrant&rsquo;s annual report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on April 17, 2018)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315223008765/ex10-2.htm"><FONT STYLE="font-size: 10pt">2023 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant&rsquo;s annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 24, 2023)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315220024009/ex10-1.htm"><FONT STYLE="font-size: 10pt">Form of Stock Subscription Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed on December 21, 2020)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315221030533/ex10-1.htm"><FONT STYLE="font-size: 10pt">Agreement and Plan of Merger, dated December 5, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on December 6, 2021)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315223008765/ex10-5.htm"><FONT STYLE="font-size: 10pt">Employment Agreement by and between Viewbix Ltd. and Amihay Hadad, dated February 23, 2023 (incorporated by reference to Exhibit 10.5 to the Registrant&rsquo;s Annual Report on Form 10-K filed with the SEC on March 25, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315223044578/ex10-1.htm"><FONT STYLE="font-size: 10pt">Loan Agreement by and between Viewbix Ltd. and the lenders thereto, dated November 15, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on December 12, 2023)</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 10px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224026343/ex10-1.htm"><FONT STYLE="font-size: 10pt">Form of Securities Purchase Agreement, dated July 3, 2024, by and between Viewbix Inc. and the purchasers parties thereto (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 5, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029747/ex10-11.htm"><FONT STYLE="font-size: 10pt">Form of July 2024 Common Stock Purchase Warrant (incorporated by reference to Exhibit 10.11 to the Registrant&rsquo;s Registration Statement on Form S-1 (File No.: 333-281143) filed with the SEC on July 31, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224026343/ex10-3.htm"><FONT STYLE="font-size: 10pt">Form of Registration Rights Agreement, dated July 3, 2024, by and between Viewbix Inc. and the purchasers parties thereto (incorporated by reference to Exhibit 10.3 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 5, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224028685/ex10-4.htm"><FONT STYLE="font-size: 10pt">Form of Amended and Restated Facility Agreement, dated July 22, 2024, by and between Capitalink Ltd. and Viewbix Inc. (incorporated by reference to Exhibit 10.4 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 22, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029747/ex10-14.htm"><FONT STYLE="font-size: 10pt">Form of First July 2024 Warrant (incorporated by reference to Exhibit 10.14 to the Registrant&rsquo;s Registration Statement on Form S-1 (File No.: 333-281143) filed with the SEC on July 31, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224028685/ex10-1.htm"><FONT STYLE="font-size: 10pt">Form of Amended and Restated Facility Agreement, dated July 22, 2024, by and between Viewbix Inc. and the lenders thereto (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 22, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029747/ex10-16.htm"><FONT STYLE="font-size: 10pt">Form of June 2024 Facility Warrants (incorporated by reference to Exhibit 10.16 to the Registrant&rsquo;s Registration Statement on Form S-1 (File No.: 333-281143) filed with the SEC on July 31, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224028685/ex10-3.htm"><FONT STYLE="font-size: 10pt">Form of June 2024 Lead Lender Warrant (incorporated by reference to Exhibit 10.3 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 22, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029529/ex10-3.htm"><FONT STYLE="font-size: 10pt">Form of Facility Agreement, dated July 28, 2024, by and between M.R.M. Merhavit Holdings and Management Ltd. and Viewbix Inc. (incorporated by reference to Exhibit 10.3 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029747/ex10-19.htm"><FONT STYLE="font-size: 10pt">Form of Second July 2024 Warrant (incorporated by reference to Exhibit 10.19 to the Registrant&rsquo;s Registration Statement on Form S-1 (File No.: 333-281143) filed with the SEC on July 31, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029736/ex10-1.htm"><FONT STYLE="font-size: 10pt">Form of Amended and Restated Securities Exchange Agreement, dated July 31, 2024, by and between Viewbix Inc. and Metagramm Software Ltd. (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 31, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000149315224029529/ex10-2.htm"><FONT STYLE="font-size: 10pt">Form of Second Amendment, dated July 25, 2024, to the Amended and Restated Facility Agreement, dated July 22, 2024, by and between Capitalink Ltd. and Viewbix Inc. (incorporated by reference to Exhibit 10.2 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on July 30, 2024)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225000368/ex10-1.htm"><FONT STYLE="font-size: 10pt">Form of Securities Exchange Agreement, dated March 24, 2025, by and between Viewbix Inc., Metagramm Software Ltd. and the Shareholders of Metagramm Software Ltd. (incorporated by reference to Exhibit 10.1 to the Registrant&rsquo;s Current Report on Form 8-K filed with the SEC on March 24, 2025)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/797542/000164117225000384/ex21-1.htm"><FONT STYLE="font-size: 10pt">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 to the Registrant&rsquo;s Registration Statement on Form S-1 (File No.: 333-281143) filed with the SEC on March 24, 2025)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="ex23-1.htm"><FONT STYLE="font-size: 10pt">Consent of Brightman Almagor Zohar &amp; Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-size: 10pt">Consent of Greenberg Traurig, P.A. (contained in Exhibit 5.1)</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Power of Attorney</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">107*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><A HREF="ex107.htm"><FONT STYLE="font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.3in"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Item 17. Undertakings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">The undersigned Registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">To file, during any period in which offers or sales are being made,
    a post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">To include any prospectus required by section 10(a)(3) of the Securities
    Act of 1933;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">To reflect in the prospectus any facts or events arising after the
    effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the
    aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
    any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
    was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of
    prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
    than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the
    effective registration statement;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">To include any material information with respect to the plan of distribution
    not previously disclosed in the registration statement or any material change to such information in the registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>provided,
however</I>, that the undertakings set forth in paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in reports with or furnished to the Securities
and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated
by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">That for the purpose of determining any liability under the Securities
    Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
    relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona
    fide offering thereof.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">To remove from registration by means of a post-effective amendment
    any of the securities being registered which remain unsold at the termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">If the registrant is relying on Rule 430B:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 144px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Each prospectus filed by the registrant pursuant to Rule 424(b)(3)
    shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the
    registration statement; and</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5),
    or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
    (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed
    to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after
    effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in
    Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to
    be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus
    relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided,
    however</I>, that No statement made in a registration statement or prospectus that is part of the registration statement or made
    in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
    registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify
    any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any
    such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If the registrant is subject to Rule 430C, each prospectus filed pursuant
    to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B
    or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement
    as of the date it is first used after effectiveness. Provided, however, that No statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">That, for the purpose of determining liability under the Securities
    Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned Registrant undertakes that in a primary
    offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the method used to sell
    the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
    the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned Registrant
    relating to the offering required to be filed pursuant to Rule 424;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any free writing prospectus relating to the offering prepared by or
    on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The portion of any other free writing prospectus relating to the offering
    containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant;
    and</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any other communication that is an offer in the offering made by the
    undersigned Registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 48px"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned registrant hereby undertakes that, for purposes of
    determining any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s annual report pursuant to Section
    13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&rsquo;s
    annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration
    statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
    securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities
    Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described
    in Item 6 hereof, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public
    policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
    (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant
    in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
    with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
    precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy
    as expressed in the Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-1 and has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Tel Aviv, State of Israel on this 20<SUP>th</SUP> day of June, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>VIEWBIX INC.</B></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 45%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><I>/s/ Amihay Hadad</I></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Amihay Hadad</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="a_013"></A>POWER OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">We,
the undersigned directors and officers of Viewbix Inc., hereby severally constitute and appoint Amihay Hadad and Shahar Marom, and each
of them severally, his or her true and lawful attorneys-in-fact and agents with full powers of substitution, for him and in his name,
place and stead, in any and all capacities, to sign any and all supplements amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorneys- in-fact and agents, or their substitute or substitutes,
may lawfully do or cause to be done by virtue thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the
capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 35%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font-size: 10pt; width: 1%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 43%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font-size: 10pt; width: 1%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 20%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Amihay Hadad</I></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Amihay Hadad</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(principal executive officer)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Shahar Marom</I></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Shahar Marom</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">(principal financial officer and principal accounting officer)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ <I>Eliyahu Yoresh</I></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chairman of the Board of&#9;Directors</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Eliyahu Yoresh</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Amitay Weiss</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Amitay Weiss</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Liron Carmel</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Liron Carmel</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ <I>Alon Dayan</I></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">June 20, 2025</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Alon Dayan</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex5-1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 0pt; text-indent: 0pt; width: 55%">&nbsp;</TD>
  <TD STYLE="padding-left: 0pt; text-indent: 0pt; width: 45%"> <P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">June
                                            20, 2025</P></TD></TR>
</TABLE>


<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viewbix
Inc.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hanehoshet
St</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building
B, 7th floor</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
Aviv, Israel 6971068</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
<U>Viewbix Inc. Registration Statement on Form S-1</U></FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel for
Viewbix Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation of a Registration Statement
on Form S-1, including the prospectus constituting a part thereof (as may be amended, the &ldquo;<U>Registration Statement</U>&rdquo;),
being filed by the Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), relating to the registration for resale under the Registration Statement
by the selling stockholder (the &ldquo;<U>Selling Stockholder</U>&rdquo;) named in the Registration Statement of 5,296,610 shares of the
Company&rsquo;s common stock, par value $0.0001 per share (&ldquo;<U>Common Stock</U>&rdquo;) issuable upon the exercise of a warrant
issued to the Selling Stockholder (the &ldquo;<U>Warrant</U>&rdquo;, and such shares of Common Stock underlying the Warrant, the &ldquo;<U>Warrant
Shares</U>&rdquo;).&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our representation of the Company, and as a basis for the opinions hereinafter set forth, we have examined originals,
or copies certified or otherwise identified to our satisfaction, of the following (collectively, the &ldquo;<U>Documents</U>&rdquo;):</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Registration Statement;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&rsquo;s Amended and Restated Certificate of Incorporation, dated August 31, 2022;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to the Company&rsquo;s Amended and Restated Certificate of Incorporation, dated July 15, 2024;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&rsquo;s Amended and Restated Bylaws, dated September 19, 2022;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">resolutions
    adopted by the Company&rsquo;s Board of Directors approving, among other things, the issuance of the Registered Shares; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">such other documents and records and other certificates and instruments and matters of law as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and qualifications stated herein.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Greenberg
Traurig, | P.A. Attorneys at Law</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azrieli
Center, Round Tower <B>|</B> 132 Menachem Begin Road, 30th Floor <B>| </B>Tel Aviv, Israel 6701101 <B>| </B>T +1 +972 (0) 3 636 6000
<B>| </B>F +1 +972 (0) 3 636 6010</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.gtlaw.com</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rendering the opinions set forth below, we have assumed: (i) the genuineness of all signatures, the legal capacity of natural persons,
the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us
as duplicates or certified or conformed copies and the authenticity of the originals of such latter documents; (ii) each individual executing
any of the Documents, whether on behalf of such individual or another person, is legally competent and authorized to do so; (iii) each
of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents
to which such party is a signatory; and (iv) the obligations of each party set forth therein are legal, valid and binding obligations
of such party and are enforceable against such party in accordance with all stated terms.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
to matters of fact, we have relied upon the Documents and, solely to the extent we deemed reasonably appropriate, upon representations
or certificates of officers or directors of the Company, without independently verifying the accuracy of such documents, records and
instruments.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based solely upon and subject
to the foregoing, and subject to the assumptions, limitations and qualifications stated herein, we are of the opinion that the Warrant
Shares have been duly authorized, and when a Warrant is exercised by the Selling Stockholder pursuant to the terms thereof, including
payment of the exercise price as provided for in the Warrant, the Warrant Shares issuable at that time by the Company to the Selling Stockholder
will be validly issued, fully paid and non-assessable.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is limited to the matters stated herein, and no opinions may be implied or inferred beyond the matters expressly stated
herein. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware
of any fact that might change the opinion expressed herein after the date hereof.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not express any opinion herein concerning any law other than the laws of the State of Delaware and the federal laws of the United
States.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of the name of our firm therein.
In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Securities
Act or the rules and regulations of the Commission promulgated thereunder.</FONT></P>

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Greenberg Traurig, P.A.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 3.5in; text-align: justify"><P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Greenberg
Traurig, | P.A. Attorneys at Law</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Azrieli
Center, Round Tower <B>|</B> 132 Menachem Begin Road, 30th Floor <B>| </B>Tel Aviv, Israel 6701101 <B>| </B>T +1 +972 (0) 3 636 6000
<B>| </B>F +1 +972 (0) 3 636 6010</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.gtlaw.com</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><IMG SRC="ex23-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
this Registration Statement on Form S-1 of our report dated March 21, 2025 relating to the consolidated financial statements of Viewbix
Inc. (the &ldquo;Company&rdquo;), appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2024. We
also consent to the reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>/s/ Brightman Almagor Zohar &amp; Co.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certified Public Accountants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A Firm in the Deloitte Global Network</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tel Aviv, Israel </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>June 20, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-1_002.jpg" ALT="" STYLE="height: 179px; width: 670px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex107.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:VBIX="http://view-bix.com/20250618">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_028_FFD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_VBIX_view%2Dbix.com_20250618 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250618_20250618 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000797542 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-18" id="Fact000003" name="dei:EntityCentralIndexKey">0000797542</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-18" id="xdx2ixbrl0009" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
  <ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="AsOf2025-06-18" id="xdx2ixbrl0024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="AsOf2025-06-18" id="xdx2ixbrl0025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-18</xbrli:startDate>
        <xbrli:endDate>2025-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-182025-06-18_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-18</xbrli:startDate>
        <xbrli:endDate>2025-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_effd--FeeExhibitTp_dxL_c20250618__20250618_zjsopbb6Yb9i" title="::XDX::EX-FILING FEES"><span style="-sec-ix-hidden: xdx2ixbrl0009">Exhibit
107</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calculation
of Filing Fee Tables</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
<span id="xdx_900_effd--FormTp_c20250618__20250618_z0qGJqMBQaTf"><span id="xdx_904_effd--SubmissnTp_c20250618__20250618_zK4FTfHfb876"><ix:nonNumeric contextRef="AsOf2025-06-18" id="Fact000010" name="ffd:FormTp"><ix:nonNumeric contextRef="AsOf2025-06-18" id="Fact000011" name="ffd:SubmissnTp">S-1</ix:nonNumeric></ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20250618__20250618_zT6Hf5C87P93"><ix:nonNumeric contextRef="AsOf2025-06-18" id="Fact000012" name="dei:EntityRegistrantName">Viewbix
Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Table
1 &#8211; Newly Registered Securities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_101_z5NkEb1CsqX5" summary="xdx: Document - Offerings" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_487_effd--OfferingSctyTp_zTCtwsZWaAWc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Security</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Type</span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_486_effd--OfferingSctyTitl_zPf5Kpw97Xti" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Security</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Class</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Title</span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fee</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Calculation</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">or
                                            Carry</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Forward</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Rule</span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_481_effd--AmtSctiesRegd_pid_zajwQxk9IhR4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>Amount</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registered<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48C_effd--MaxOfferingPricPerScty_pid_zoB7cT6R9Pd9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Proposed
                                            Maximum</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Offering
                                            Price Per Unit</span></p></td><td style="padding-bottom: 5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48F_effd--MaxAggtOfferingPric_pid_zjG9BOp9ohpc" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximum
                                            Aggregate</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offering
                                            Price<sup>(4)</sup></b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_488_effd--FeeRate_pid_zPr46Vgh2vo8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Fee
    Rate</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48B_effd--FeeAmt_pid_zVb55118lE7h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Amount
                                            of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Registration
                                            Fee</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_414_20250618__20250618__ffd--OfferingAxis__1_zQoxhcYHVafb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_989_effd--PrevslyPdFlg_dbF_c20250618__20250618__ffd--OfferingAxis__1_zMRXHg3F7Zhl" style="width: 9%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-06-182025-06-18_1" format="ixt:booleanfalse" id="Fact000020" name="ffd:PrevslyPdFlg">Fees to Be Paid</ix:nonNumeric></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-06-182025-06-18_1" id="Fact000013" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-06-182025-06-18_1" id="Fact000014" name="ffd:OfferingSctyTitl">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td id="xdx_982_effd--FeesOthrRuleFlg_dbT_c20250618__20250618__ffd--OfferingAxis__1_zl2mPQFq9zW" style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-06-182025-06-18_1" format="ixt:booleantrue" id="Fact000021" name="ffd:FeesOthrRuleFlg">&#160;Rule 457(c)</ix:nonNumeric></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2025-06-182025-06-18_1" id="Fact000015" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,296,610</ix:nonFraction></span></td><td style="padding-bottom: 5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(2)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" contextRef="From2025-06-182025-06-18_1" id="Fact000016" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.955</ix:nonFraction></span></td><td style="padding-bottom: 5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><sup>(3)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-06-182025-06-18_1" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">20,948,092.55</ix:nonFraction></span></p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:FeeRate" contextRef="From2025-06-182025-06-18_1" id="Fact000018" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0.0001531</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-06-182025-06-18_1" id="Fact000019" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">3,207.16</ix:nonFraction></span></p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fees Previously Paid</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total Offering
    Amounts</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p id="xdx_98F_effd--TtlOfferingAmt_pid_c20250618__20250618_zpc05mWS3wSh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="AsOf2025-06-18" id="Fact000022" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">20,948,092.55</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p id="xdx_98E_effd--TtlFeeAmt_pid_c20250618__20250618_zXSsxnxWJmOf" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="AsOf2025-06-18" id="Fact000023" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">3,207.16</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total Fees
    Previously Paid</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$ </span></td><td id="xdx_986_effd--TtlPrevslyPdAmt_c20250618__20250618_zHKUl69sLYme" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0024">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total Fee
    Offsets</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_effd--TtlOffsetAmt_c20250618__20250618_zD7W1awYTbl3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0025">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="10" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net Fee Due</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p id="xdx_988_effd--NetFeeAmt_pid_c20250618__20250618_zRGN2AiQYyu8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="AsOf2025-06-18" id="Fact000026" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">3,207.16</ix:nonFraction></span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td id="xdx_98E_effd--OfferingNote_c20250618__20250618__ffd--OfferingAxis__1_gBFON-TPLOYL_z3YTN3Uaatxc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:nonNumeric contextRef="From2025-06-182025-06-18_1" continuedAt="ConU000030-01" escape="true" id="Fact000030" name="ffd:OfferingNote"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;), this registration
    statement shall also cover any additional shares of common stock, par value $0.0001 per share (&#8220;<span style="text-decoration: underline">common stock</span>&#8221;),
    of Viewbix Inc. (the &#8220;<span style="text-decoration: underline">Registrant</span>&#8221;), that may be offered or become issuable <span style="background-color: white">by
    reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration
    which results in an increase in the number of outstanding shares of common stock.</span></span></ix:nonNumeric></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_C0A_gBFON-TPLOYL_zw9H2ww33RM6"><ix:continuation continuedAt="ConU000030-02" id="ConU000030-01">Consists of 5,296,610 shares of the Registrant&#8217;s common
                                                                              stock issuable upon the exercise of a warrant issued in connection with a credit facility that the Registrant&#8217;s entered into
                                                                              in June 2024. All 5,296,610 shares of common stock are to be offered for resale by the selling stockholder named in the prospectus
                                                                              contained in this Registration Statement on Form S-1.</ix:continuation></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_C01_gBFON-TPLOYL_zztLlNEAvLOh"><ix:continuation continuedAt="ConU000030-03" id="ConU000030-02">Estimated solely for purposes of calculating the registration fee
                                                                              in accordance with Rule 457(c) under the Securities Act and based upon the average of the high ($4.30) and low ($3.61) sale prices
                                                                              of the Registrant&#8217;s shares of common stock on the Nasdaq Capital Market on June 17, 2025.</ix:continuation></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_C0E_gBFON-TPLOYL_zShx2dQBopj2"><ix:continuation id="ConU000030-03">The Registrant will not receive any proceeds from the sale of shares
of its common stock by the selling stockholder.</ix:continuation></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="border-bottom: Black 1pt solid; text-align: center; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdrNH3R3OuYQp8gQ8ba4KMWtGWn9eyTf0rohhkBIzvlyhOiJjJa6Qobjoshhj3VTKYdQ4BkZzQm9I1mtY/CzwIu2jpVx7foDE/IMembSlyd/b513bbGMQU4G4XQQjUEO49EM5hsRfPWEzFmXaJxWFShTwo6pYY1O8av7sFdPMlS/2qQDstVkYgj7spPfEMkwgi3d1YP4aiHPExH02gpExnRrvCt9OjRfEtIKax9nO/rfwQfJXkpY -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N .L# 2(  A$! Q$!_\0
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M3!?037%\DL2.&:,1GY@.W6O0:Z<VQ].M"-*B[K=_H<N3Y?5HSE5K*SV7ZO\
M0Y;X@_\ (J2?]=4KR =:]R\1Z.VNZ0UDDPB)<-N(STKC?^%83Y_Y"4?_ '[/
M^-;95C:%"@X5)6=WW,,WP&(KXCGI1NK+MY^9K^(]+DU/P):&%2TMO#'*%'4@
M+@C\CG\*\I'#=.AZ5] 6<!M;&WMRP8Q1JA('7 Q7*:W\/;+4;AKFRF^R2,<L
MFW*$^P[5GEV94Z/-3J[7;3]37,\KJ5N6K2^*R37H)IFN>$KO3XY;BWL+><*/
M,C>W7(/?''(K+N?&7AR*[>.'P_;S0J<"7RT7=^&VJ3?#/5PQVW=B5[$LX/\
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I'*L/R]JFK)TC2I],+*9P\3<E<=#ZBM:O+J**DU!W1Z]*4Y03FK,__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N .L# 2(  A$! Q$!_\0
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M3!?037%\DL2.&:,1GY@.W6O0:Z<VQ].M"-*B[K=_H<N3Y?5HSE5K*SV7ZO\
M0Y;X@_\ (J2?]=4KR =:]R\1Z.VNZ0UDDPB)<-N(STKC?^%83Y_Y"4?_ '[/
M^-;95C:%"@X5)6=WW,,WP&(KXCGI1NK+MY^9K^(]+DU/P):&%2TMO#'*%'4@
M+@C\CG\*\I'#=.AZ5] 6<!M;&WMRP8Q1JA('7 Q7*:W\/;+4;AKFRF^R2,<L
MFW*$^P[5GEV94Z/-3J[7;3]37,\KJ5N6K2^*R37H)IFN>$KO3XY;BWL+><*/
M,C>W7(/?''(K+N?&7AR*[>.'P_;S0J<"7RT7=^&VJ3?#/5PQVW=B5[$LX/\
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I'*L/R]JFK)TC2I],+*9P\3<E<=#ZBM:O+J**DU!W1Z]*4Y03FK,__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  F .T# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U / # 2(  A$! Q$!_\0
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MB>,Q_+L7G![<5R/[/W_(RZS_ ->:?^AUZW\0;F2S^'^O31$AQ9NH([9&/ZT
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MWN8E%H4$MP NYG! P 3T(KS$_ [Q@)MH;32N?O\ V@X_+;FO3?AE\.[OP/\
M;IKV_AN)KQ44QPH=J;<]SUZ^@H ^:YH);:>6WN(VCFB8QR(PP58'!%>R>"?&
M?P_?0K6T\0:786NH6Z")YI+(.LV. VX \GOGO77^-_A1IGBZ=]1MI3I^J,/G
ME5=R2^F]?7W'ZUYM<? SQ=%*5AETV=.SB9E_0K0!V&H>./A39X$&E6EXY(&(
M=.  ]R6 &*]#D&F^&]&EGTZRMX86(81P($5V. "<?A7BMA\!?$%PX%_J-A:Q
M'[WE[I6Q[# 'ZU[<VB*WAR'27G9S%"D8F8<DJ  Q'X5G4YN1\N_0F5[:'+IX
MLU19_,=XW3/,>S Q]>M=U:7"7=K'<)G9(H89]ZXF/P?J#3['DB6+/,@.>/85
MVUM EK;1P1C"1J%'T%<&#59.7M+V\S&CSZ\Q9HHHKTS<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #5 QT# 2(  A$! Q$!_\0
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MN,=.].T/7FT^%;B>29]/FMY)U29_,:)T8*0&[@D]: .\+$'!Z>OK2G)'!Q7
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M]_9R=W3K7H-% '!^'K6:/6M-D?3]1A2WL?LI,UN%4D=\YXKMV!]6!]N14M%
M"$X&:3<1C^E1W<I@LYIAC,:%N?89KA;+XE6L7AZPO-2A=KRZ$DC0VPW;(U9A
MN/X"@#O\TA)KE?\ A/\ 2)+^ULK1+JYGN(1.HBBW!4/=N>*DB\=:1-:6-ROG
M".^GDMXLK@[TSNSZ?=.* .GS29.>M<OI7C6RUJ*]EL[.[:"UR"[)C<0<%1SU
MK%U?XAB7P[<76CQO'>VUY#;RQ7"8*AW S^1H ]#R>O;THS7)S?$'1K?6O[,E
M:4,)1 9PO[OS<9VYJH_Q/T47 C%I?R*TS6\;K#D/,I.4'/)XH [<'GVI:Q_#
MWB&T\1V+W5J)8S'(T4D4J[7C8'D$>M;% !1110 4444 %%%% !1110 4C'%+
M36XYH  3N ^M.JK'.[:A+"=FQ55@,_-SZBK5 !2,2,8_&EIK>M !D_6C=_\
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M\N/)4KG((]<BJ6F_$FT_MG4+'5D> Q7@@@D"94@@8W'L<T >@44FX<>_2EH
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M3RBRF4KY&1M4'GCBMBW@6WA2-"<*N 2>M2 '\*4=>10 M%%% !1110 4444
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M6Z<]* *<1']K3C*?ZM>/XJO51C;_ (FLR[F_U:_+C@?C5Z@ I#UI::WKS]*
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MHH **** "BBB@ I#TI:0]* (KD@6\F2 -O>G0_ZE/I27'$$AS_#2P_ZE/I0
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MGZ5)BDQ0 T\GI^&:9Y<:L3Y:@GJ0O)J;%% $*PHN0(T&>H  S0$"C8% 3'0
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M -5&10 M%)N!&11F@!:*3/6C(QF@!:*;N^O7%&X9QGI0 ZBDW#&>GUHW#.*
M%HI,B@$$4 +129I: "D/2EI#TH BN,_9Y.OW>U+#_JEI+C_42<9^7UQ3H?\
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MH+6T@NH;-KA9Y6:0>42.I ZY_2M..UO#K-YJ<T)9;>+RK*(-]_CEO8G./PH
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M:YD\R00C"+Z!1VH VAU-+30>HSFEW# /K0 M%)D9Q2T %%%% !1110 4444
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(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000797542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Viewbix
Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jun. 18, 2025 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">5,296,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="nump">3.955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 20,948,092.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 3,207.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;), this registration
    statement shall also cover any additional shares of common stock, par value $0.0001 per share (&#8220;<span style="text-decoration: underline">common stock</span>&#8221;),
    of Viewbix Inc. (the &#8220;<span style="text-decoration: underline">Registrant</span>&#8221;), that may be offered or become issuable <span style="background-color: white">by
    reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration
    which results in an increase in the number of outstanding shares of common stock.</span></span>Consists of 5,296,610 shares of the Registrant&#8217;s common
                                                                              stock issuable upon the exercise of a warrant issued in connection with a credit facility that the Registrant&#8217;s entered into
                                                                              in June 2024. All 5,296,610 shares of common stock are to be offered for resale by the selling stockholder named in the prospectus
                                                                              contained in this Registration Statement on Form S-1.Estimated solely for purposes of calculating the registration fee
                                                                              in accordance with Rule 457(c) under the Securities Act and based upon the average of the high ($4.30) and low ($3.61) sale prices
                                                                              of the Registrant&#8217;s shares of common stock on the Nasdaq Capital Market on June 17, 2025.The Registrant will not receive any proceeds from the sale of shares
of its common stock by the selling stockholder.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 20,948,092.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">3,207.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 3,207.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ex107.htm">ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024q2": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 18,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-18",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-18",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-06-182025-06-18_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-06-182025-06-18_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-18",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-18",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001641172-25-015686-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-015686-xbrl.zip
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ME   "0              @ $     97@Q,#<N:'1M4$L%!@     !  $ -P
' *@1      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-06-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="From2025-06-182025-06-18_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797542</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-18" id="Fact000003">0000797542</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2025-06-18" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-06-18"
      id="xdx2ixbrl0024"
      unitRef="USD"
      xsi:nil="true"/>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-06-18"
      id="xdx2ixbrl0025"
      unitRef="USD"
      xsi:nil="true"/>
    <ffd:FormTp contextRef="AsOf2025-06-18" id="Fact000010">S-1</ffd:FormTp>
    <ffd:SubmissnTp contextRef="AsOf2025-06-18" id="Fact000011">S-1</ffd:SubmissnTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-18" id="Fact000012">Viewbix Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="From2025-06-182025-06-18_1" id="Fact000020">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="From2025-06-182025-06-18_1" id="Fact000013">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-06-182025-06-18_1" id="Fact000014">Common stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-06-182025-06-18_1" id="Fact000021">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2025-06-182025-06-18_1"
      decimals="INF"
      id="Fact000015"
      unitRef="Shares">5296610</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2025-06-182025-06-18_1"
      decimals="INF"
      id="Fact000016"
      unitRef="USDPShares">3.955</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-06-182025-06-18_1"
      decimals="INF"
      id="Fact000017"
      unitRef="USD">20948092.55</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2025-06-182025-06-18_1"
      decimals="INF"
      id="Fact000018"
      unitRef="Ratio">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2025-06-182025-06-18_1"
      decimals="INF"
      id="Fact000019"
      unitRef="USD">3207.16</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-06-18"
      decimals="INF"
      id="Fact000022"
      unitRef="USD">20948092.55</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-06-18"
      decimals="INF"
      id="Fact000023"
      unitRef="USD">3207.16</ffd:TtlFeeAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-06-18"
      decimals="INF"
      id="Fact000026"
      unitRef="USD">3207.16</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-06-182025-06-18_1" id="Fact000030">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
    to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#x201c;&lt;span style="text-decoration: underline"&gt;Securities Act&lt;/span&gt;&#x201d;), this registration
    statement shall also cover any additional shares of common stock, par value $0.0001 per share (&#x201c;&lt;span style="text-decoration: underline"&gt;common stock&lt;/span&gt;&#x201d;),
    of Viewbix Inc. (the &#x201c;&lt;span style="text-decoration: underline"&gt;Registrant&lt;/span&gt;&#x201d;), that may be offered or become issuable &lt;span style="background-color: white"&gt;by
    reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration
    which results in an increase in the number of outstanding shares of common stock.&lt;/span&gt;&lt;/span&gt;Consists of 5,296,610 shares of the Registrant&#x2019;s common
                                                                              stock issuable upon the exercise of a warrant issued in connection with a credit facility that the Registrant&#x2019;s entered into
                                                                              in June 2024. All 5,296,610 shares of common stock are to be offered for resale by the selling stockholder named in the prospectus
                                                                              contained in this Registration Statement on Form S-1.Estimated solely for purposes of calculating the registration fee
                                                                              in accordance with Rule 457(c) under the Securities Act and based upon the average of the high ($4.30) and low ($3.61) sale prices
                                                                              of the Registrant&#x2019;s shares of common stock on the Nasdaq Capital Market on June 17, 2025.The Registrant will not receive any proceeds from the sale of shares
of its common stock by the selling stockholder.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
